Bristol Myers to Acquire the Drugmaker Karuna for $14 Billion

Written by

in

The deal is a bet on the growing market for psychiatric and neurological drugs.

Author: Lauren Hirsch

Bristol Myers Squibb Company Drugs (Pharmaceuticals) Food and Drug Administration Karuna Therapeutics Inc Mental Health and Disorders Mergers, Acquisitions and Divestitures

Comments

Leave a ReplyCancel reply

This site uses Akismet to reduce spam. Learn how your comment data is processed.

More posts

The Wife of Haiti’s Assassinated President Is Accused in His Killing

February 19, 2024
Israeli military operations reduce the functioning of two hospitals in southern Gaza to nearly nothing.

February 19, 2024
Brazil’s President Lula Recalls Ambassador to Israel, Escalating a Dispute

February 19, 2024
On Tom Suozzi and the Long Island Special Election

February 19, 2024